Abraxis BioScience Financial Market Data
| Last Close 03-Oct-2008 |
$67.49 |
Price/ Sales Ratio |
8.18 |
| 52-Week High |
$78.95 |
Price/ Book Ratio |
2.28 |
| 52-Week Low |
$33.00 |
Price/ Earnings Ratio |
-- |
| 60-Month Beta |
-- |
Price/ Cash Flow Ratio |
-- |
| Market Cap (mil.) |
$2,701.5 |
Return on Assets |
0.0% |
| Shares Outstanding (mil.) |
40.0 |
Return on Equity |
0.0% |
| Dividend Rate |
-- |
Current Ratio |
6.18 |
| Dividend Yield |
-- |
Long-Term Debt/Equity |
-- |
| # of Institutional Holders |
72 |
% Owned by Institutions |
14.0% |
| Latest Short Interest Ratio |
5.91 |
Latest Net Insider Transactions |
-- |
| Revenue Growth |
0.0% |
0.0% |
0.0% |
| EPS Growth |
0.0% |
0.0% |
0.0% |
| Dividend Growth |
0.0% |
0.0% |
0.0% |
This data is provided as per license from EDGAR Online
